Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Episode | Date |
---|---|
Cancer Topics - Oncology Practice in Low-Resource Settings
|
Oct 11, 2023 |
Cancer Topics - Oncology Practice In Rural Settings Part 2
|
Sep 13, 2023 |
Oncology, Etc. – Dr. Patricia Ganz’ Evolutionary Treatment Of The Whole Patient
|
Sep 05, 2023 |
Cancer Topics – ICC Program Malaysia
|
Aug 16, 2023 |
Oncology, Etc. – The Diversity Mission with Dr Edith Mitchell
|
Aug 08, 2023 |
Cancer Topics – Research to Practice: Prostate Cancer (Part 2)
|
Jul 19, 2023 |
Oncology, Etc. – Dr. Lori Pierce’s Path From Engineering To Oncology
|
Jul 11, 2023 |
Cancer Topics - Oncology Practice In Rural Settings Part 1
|
Jun 21, 2023 |
Oncology, Etc. – Pioneering Geriatric Cancer Care with Dr. Hyman Muss
|
Jun 13, 2023 |
Cancer Topics – Alternative to 10-Year ABIM MOC Exam: Longitudinal Knowledge Assessment
|
May 18, 2023 |
Cancer Topics – Research to Practice: Prostate Cancer (Part 1)
|
May 10, 2023 |
Oncology, Etc. – Devising Medical Standards and Training Master Clinicians with Dr. John Glick
|
May 02, 2023 |
Cancer Topics - How To Keep Up With Advances In Oncology
|
Apr 12, 2023 |
Oncology, Etc: - Cancer Care Partnership With Kenya
|
Apr 04, 2023 |
Cancer Topics - Racial Disparities in Clinical Trial Participation
|
Mar 15, 2023 |
Oncology, Etc. - Passion For Writing And Medicine With Dr. Lisa Rosenbaum
|
Mar 07, 2023 |
Advanced Practice Providers - APPs in Oncology
|
Feb 23, 2023 |
Oncology Etc: Dr. Miriam Mutebi on Improving Cancer Care in Africa
|
Feb 07, 2023 |
Oncology Etc – Global Cancer Policy Leader Dr. Richard Sullivan Part 2
|
Jan 24, 2023 |
Cancer Topics - My Approach to Refractory Diffuse Large B-Cell Lymphoma
|
Jan 18, 2023 |
Oncology, Etc. – Global Cancer Policy Leader Dr. Richard Sullivan (Part 1)
|
Jan 10, 2023 |
Cancer Topics – Oncology Training – Past, Present, Future Part 2
|
Dec 21, 2022 |
Cancer Topics – Oncology Training – Past, Present, Future Part 1
|
Dec 14, 2022 |
Oncology, Etc. – HPV Vaccine Pioneer Dr. Douglas Lowy (Part 2)
|
Dec 13, 2022 |
Oncology, Etc. – HPV Vaccine Pioneer Dr. Douglas Lowy (Part 1)
|
Dec 06, 2022 |
Oncology, Etc. – In Conversation with Dr. David Steensma (Part 2)
|
Nov 15, 2022 |
Cancer Topics - Impact of Implicit Racial Bias on Oncology Patient Care and Outcomes
|
Nov 09, 2022 |
Oncology, Etc. - In Conversation with Dr. David Steensma (Part 1)
|
Nov 01, 2022 |
Advanced Practice Providers - An APP’s Scope of Practice
|
Oct 17, 2022 |
Cancer Topics - Increasing Diversity in Oncology Practices (Part 2)
|
Oct 12, 2022 |
Oncology, Etc. - In Conversation with Dr. Peter Bach (Part 2)
|
Oct 04, 2022 |
Cancer Topics - Increasing Diversity in Oncology Practices (Part 1)
|
Sep 14, 2022 |
Oncology, Etc. - In Conversation with Dr. Peter Bach (Part 1)
|
Sep 13, 2022 |
Advanced Practice Providers – APPs 101: Physician Assistants (PAs) and Advanced Practice Registered Nurses (APRNS) in Oncology
|
Aug 31, 2022 |
Oncology, Etc. - Finding Your Voice: A Tale of Healing and Rediscovery
|
Jul 19, 2022 |
Cancer Topics - Career Paths in Oncology (Part 2)
|
Jul 13, 2022 |
Oncology, Etc. – In Conversation with Dr. Richard Pazdur (Part 2)
|
Jun 28, 2022 |
Cancer Topics - Career Paths in Oncology (Part 1)
|
Jun 22, 2022 |
Advanced Practice Providers - APPs 101: What and Who Are Advanced Practice Providers (APPs)?
|
Jun 21, 2022 |
Oncology, Etc. – In Conversation with Dr. Richard Pazdur (Part 1)
|
Jun 14, 2022 |
Cancer Topics – Financial Toxicity
|
May 18, 2022 |
Oncology, Etc. – Rediscovering the Joy in Medicine with Dr. Deborah Schrag (Part 2)
|
May 17, 2022 |
Oncology, Etc. – Rediscovering the Joy in Medicine with Dr. Deborah Schrag (Part 1)
|
May 03, 2022 |
Oncology, Etc. – Mr. Paul Goldberg: Interviewing the Interviewer (Part 2)
|
Apr 19, 2022 |
Cancer Topics – Medical Aid in Dying
|
Apr 13, 2022 |
Oncology, Etc. – Mr. Paul Goldberg: Interviewing the Interviewer (Part 1)
|
Apr 05, 2022 |
Oncology, Etc. — Out of this World: Astronaut Physicians (Part 2)
|
Mar 22, 2022 |
Cancer Topics – Delivering Serious News (Part 2)
|
Mar 16, 2022 |
Oncology, Etc. - Out of this World: Astronaut Physicians (Part 1)
|
Mar 01, 2022 |
Cancer Topics – Delivering Serious News (Part 1)
|
Feb 16, 2022 |
Oncology, Etc. - Female Leadership in Practice: Two ASCO Leadership Development Program Success Stories
|
Feb 01, 2022 |
Cancer Topics – Medicinal Cannabis
|
Jan 19, 2022 |
Oncology, Etc. - In Conversation with Dr. Quyen Chu
|
Jan 04, 2022 |
Cancer Topics – Beyond Adjuvant Chemotherapy: Precision Oncology in Early-stage NSCLC
|
Dec 15, 2021 |
Oncology, Etc. - From Personal to Politics – A Discussion about COVID and Oncology
|
Dec 07, 2021 |
Oncology, Etc. - On Leadership and Pearls of Life with Dr. Susan Desmond-Hellmann (Part 2)
|
Nov 18, 2021 |
Cancer Topics - New Therapies for Lymphoma (Part 2)
|
Nov 15, 2021 |
Oncology, Etc. – On Leadership and Pearls of Life with Dr. Susan Desmond-Hellmann (Part 1)
|
Nov 04, 2021 |
Cancer Topics - New Therapies for Lymphoma (Part 1)
|
Oct 15, 2021 |
Oncology, Etc. - In Conversation with Dr. Otis Brawley (Part 2)
|
Oct 05, 2021 |
Oncology, Etc. - Introducing Oncology, Etc.: Friendship, and the Majesty of our Profession
|
Aug 03, 2021 |
Cancer Topics - Young-onset Colorectal Cancer
|
Jul 28, 2021 |
Cancer Topics - Burnout in Oncology: Trainee Perspective
|
Jul 14, 2021 |
Cancer Topics - Burned Out? Here's What You Can Do About It (Part 2)
|
Jun 30, 2021 |
Cancer Topics - Burned Out? Here's What You Can Do About It (Part 1)
|
Jun 16, 2021 |
Cancer Topics - COVID-19’s Impact on Oncology Trainees
|
May 26, 2021 |
Cancer Topics - Can You Hear Me Now? Challenges and Benefits of Telemedicine
|
May 21, 2021 |
Cancer Topics - Role of PARP Inhibitors in Prostate Cancer
|
May 10, 2021 |
Cancer Topics - Immunotherapy Breakthroughs in Esophageal Cancers
|
Apr 21, 2021 |
Cancer Topics - Adjusting Cancer Care During Covid-19
|
Apr 08, 2021 |
Cancer Topics - Exercise Can Benefit Our Cancer Patients
|
Feb 03, 2021 |
Cancer Topics - CAR T-cells in Pediatric ALL
|
Sep 22, 2020 |
Cancer Topics - Contrasting Cases: EGFR Mutant NSCLC
|
Aug 03, 2020 |
Cancer Topics - Contrasting Cases: Long-Term Outcomes and Responses to Retreatment in Patients With Melanoma Treated With PD-1 Blockade
|
May 20, 2020 |
Cancer Topics - Contrasting Cases: Cultural Barriers to Care
|
Apr 22, 2020 |
Cancer Topics - Contrasting Cases: Systemic Therapy for Metastatic Triple-negative Breast Cancer
|
Mar 11, 2020 |
Cancer Topics - Recent Approvals: Erdafitinib and Enfortumab for Second-Line Treatment of Metastatic Bladder Cancer
|
Feb 12, 2020 |
Cancer Topics - ASCO Guidelines: Molecular Biomarkers in Localized Prostate Cancer Guideline
|
Dec 18, 2019 |
Cancer Topics - ASCO Guidelines: Patient-Centered Standards for Medically Integrated Dispensing: ASCO/NCODA Standards
|
Dec 11, 2019 |
Cancer Topics - ASCO Guidelines: Disease Management for Patients With Advanced HER2 Positive Breast Cancer and Brain Metastases Guideline
|
Nov 20, 2019 |
Cancer Topics - ASCO Guidelines: Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx Guideline
|
Nov 13, 2019 |
Cancer Topics - ASCO Guidelines: Antimicrobial Prophylaxis for Adult Patients with Cancer-Related Immunosuppression Guideline
|
Nov 06, 2019 |
Cancer Topics - ASCO Guidelines: Treatment of Patients with Early-Stage Colorectal Cancer Resource-Stratified Guideline
|
Oct 30, 2019 |
Cancer Topics - ASCO Guidelines: Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision-Making for Early-Stage, Operable Breast Cancer Update
|
Oct 23, 2019 |
Cancer Topics - ASCO Voices 2019: I Promised
|
Oct 16, 2019 |
Cancer Topics - ASCO Guidelines: Medication-Related Osteonecrosis of the Jaw Guideline
|
Oct 09, 2019 |
Cancer Topics - ASCO Voices 2019: Whose Breast Is It Anyway? Breast Cancer and Sexuality in Sub-Saharan Africa
|
Oct 02, 2019 |
Cancer Topics - ASCO Guidelines: Management of Osteoporosis in Survivors of Adult Cancers with Nonmetastatic Disease Guideline
|
Sep 25, 2019 |
Cancer Topics - ASCO Guidelines: Venous Thromboembolism Prophylaxis and Treatment in Patients with Cancer Guideline Update
|
Sep 18, 2019 |
Cancer Topics - ASCO Voices 2019: The Obligation of the Cured
|
Sep 11, 2019 |
Cancer Topics - ASCO Guidelines: Use of Endocrine Therapy for Breast Cancer Risk Reduction Guideline
|
Sep 04, 2019 |
Cancer Topics - Recent Approvals: Trastuzumab and Hyaluronidase-oysk
|
Aug 21, 2019 |
ASCO Voices 2019: Surgery Is Never Elegant When Women Are in the Operating Room
|
Aug 14, 2019 |
ASCO Guidelines: Use of Biomarkers to Guide Decisions on Adjuvant Therapy for Early-Stage Invasive Breast Cancer Guideline Update
|
Aug 07, 2019 |
ASCO Guidelines: Radiation Therapy for Glioblastoma
|
Aug 01, 2019 |
ASCO Guidelines: HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma
|
Aug 01, 2019 |
ASCO Guidelines: Role of Treatment Deintensification in the Management of p16+ Oropharyngeal Cancer PCO
|
Jul 31, 2019 |
ASCO Guidelines: Duration of Oxaliplatin-Containing Adjuvant Therapy for Stage III Colon Cancer Guideline
|
Jul 24, 2019 |
ASCO Guidelines: Management of Cancer-associated Anemia with Erythropoiesis-Stimulating Agents Guideline
|
Jul 17, 2019 |
Annual Meeting 2019 - EGFR Inhibitors
|
Jul 10, 2019 |
Annual Meeting 2019 - Hepatocellular Carcinoma
|
Jul 03, 2019 |
Annual Meeting 2019 - PD1 Inhibitor Resistance in PDL1 Overexpressed Tumor
|
Jun 26, 2019 |
Annual Meeting 2019 - Managing Burnout in Oncology
|
Jun 19, 2019 |
Annual Meeting 2019 - Beyond Anti-PD-1/PD-L1 Therapy in Urothelial Cancer
|
Jun 05, 2019 |
Annual Meeting 2019 - Clinical Conundrums in the Management of Rectal Cancer
|
Jun 03, 2019 |
Annual Meeting 2019 - Clinical Conundrums in the Management of Rectal Cancer
|
Jun 03, 2019 |
Annual Meeting 2019 - Integrating Biomarkers and Targeted Therapy into Colorectal Cancer Management
|
Jun 02, 2019 |
Annual Meeting 2019 - The Role of Adjuvant Radiotherapy in Management of Nodal Disease
|
Jun 01, 2019 |
Annual Meeting 2019 - Disparities in Prostate Care
|
Jun 01, 2019 |
Annual Meeting 2019 - The Stage IV Melanoma: What Biomarkers and Treatments Are Appropriate in the Frontline Setting?
|
May 31, 2019 |
Annual Meeting 2019 - Sustainable Oncology Research Programs
|
May 29, 2019 |
Annual Meeting 2019 - Contrasting Cases: Molecular Profiling in Breast Cancer
|
May 22, 2019 |
Immunotherapy and Changes in Standard Practice in Local Regionally Advanced Non-Small Cell Lung Cancer
|
May 15, 2019 |
Self-Evaluation: Central Nervous System
|
May 08, 2019 |
Self-Evaluation: Head & Neck Cancer
|
May 01, 2019 |
ASCO Guidelines: Safe Handling of Hazardous Drugs
|
Apr 24, 2019 |
Contrasting Cases: Frontline Immunotherapy in Metastatic Non-Small Cell Lung Cancer
|
Apr 17, 2019 |
Contrasting Cases: Cancer Prevention
|
Apr 10, 2019 |
ASCO Guidelines: Treatment of Multiple Myeloma
|
Apr 03, 2019 |
ASCO Guidelines: Anticonvulsant Prophylaxis and Steroid Use in Adults with Metastatic Brain Tumors Endorsement
|
Mar 27, 2019 |
ASCO Guidelines: Adjuvant Therapy for Resected Biliary Tract Cancer
|
Mar 20, 2019 |
Self-Evaluation: Chemotherapy Dosing for Patients with Morbid Obesity
|
Mar 13, 2019 |
Contrasting Cases: TAILORx- Chemotherapy or no?
|
Mar 06, 2019 |
Self-Evaluation: Soft-Tissue Sarcomas-Epidemiology
|
Feb 27, 2019 |
ASCO Guidelines: Adjuvant Endocrine Therapy for Women with Hormone Receptor Positive Breast Cancer Guideline
|
Feb 20, 2019 |
Contrasting Cases: Nephrectomy
|
Feb 13, 2019 |
Recent Approvals: Larotrectinib for the Treatment of Advanced Solid Tumors Containing NTRK Gene Fusion
|
Feb 06, 2019 |
Recent Approvals: Duvelisib for Adult Patients with Relapsed or Refractory CLL or SLL
|
Jan 30, 2019 |
ASCO Guidelines: Evaluating Susceptibility to Pancreatic Cancer PCO
|
Jan 16, 2019 |
ASCO Guidelines: Hypofractionated Radiation Therapy for Localized Prostate Cancer Guideline
|
Jan 09, 2019 |
Recent Approvals: Cemiplimab Approval for Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma
|
Jan 02, 2019 |
ASCO Guidelines: Initial Diagnostic Workup of Acute Leukemia Guideline
|
Dec 19, 2018 |
New Drugs: Ivosidenib for Relapsed or Refractory Acute Myeloid Leukemia with Susceptible IDH1 Mutation
|
Dec 12, 2018 |
Self-Assessment: Predictive and Prognostic Rule of Pathological Complete Response in Breast Cancer Treatment
|
Dec 05, 2018 |
Recent Drug Approvals: Lenvatinib Treatment of Unresectable Hepatocellular Carcinoma (HCC)
|
Nov 28, 2018 |
Self-Evaluation: Multiple Myeloma and Plasma Cell Dyscrasias- MGUS
|
Nov 14, 2018 |
Self-Evaluation: Lung Cancer Screening
|
Nov 07, 2018 |
ASCO Guideline: HER2 Testing in Breast Cancer
|
Oct 31, 2018 |
Self-Evaluation: Non-Small Cell Lung Cancer (NSCLC) - Locally Advanced
|
Oct 24, 2018 |
ASCO Guideline: Metastatic Pancreatic Cancer
|
Oct 17, 2018 |
Self-Evaluation: Treatment of Multiple Myeloma Plasma Cell Leukemia
|
Oct 10, 2018 |
Annual Meeting 2018 - ASCO Voices: Did You Ever Know That You're My Hero
|
Oct 03, 2018 |
Self-Evaluation: Gastric Cancer Diagnosis
|
Sep 26, 2018 |
ASCO Guideline: Practical Assessment and Management of Vulnerabilities
|
Sep 19, 2018 |
Self-Evaluation: Small Cell Lung Cancer
|
Sep 12, 2018 |
Recently Approved Drugs: Nivolumab for patients with metastatic small cell lung cancer
|
Sep 05, 2018 |
ASCO Guideline: Palliative Care in the Global Setting
|
Aug 29, 2018 |
Annual Meeting 2018 - ASCO Voices: Heroes, Mentors, and Hope
|
Aug 22, 2018 |
Self-Evaluation: Breast - Partial Mastectomy Follow-Up
|
Aug 08, 2018 |
Special Episode: Non-Hodgkin Lymphoma
|
Aug 01, 2018 |
Annual Meeting 2018 - ASCO Voices: The Call
|
Jul 25, 2018 |
Recently Approved Drugs: Lutetium Lu 177 dotatate for treatment of GEP-NETs
|
Jul 18, 2018 |
ASCO Guideline: Antiemetics Guideline for Treatment-Induced Nausea and Vomiting
|
Jul 11, 2018 |
Self-Evaluation: Breast
|
Jul 03, 2018 |
Recently Approved Drugs: Durvalumab for patients with stage III Non-Small Cell Lung Cancers (NSCLC)
|
Jun 27, 2018 |
Self-Evaluation: Special histologies - lymphoma: Primary CNS, appropriate first line therapy for newly diagnosed primary CNS lymphoma
|
Jun 20, 2018 |
ASCO Guideline: Fertility Preservation in Patients with Cancer
|
Jun 13, 2018 |
Self-Evaluation: EGFR Mutation
|
Jun 06, 2018 |
Recently Approved Drugs: Olaparib for germline BRCA-mutated metastatic breast cancer
|
May 30, 2018 |
ASCO Guidelines: Outpatient Management of Fever and Neutropenia
|
May 23, 2018 |
Self-Evaluation: NSCLC Treatment Metastatic
|
May 16, 2018 |
Adjuvant Treatment in Melanoma: Recent Advances
|
May 09, 2018 |
Recently Approved Drugs: Blinatumomab for B-cell precursor ALL
|
May 02, 2018 |
Guidelines: Management of Immune-Related Adverse Events
|
Apr 25, 2018 |
Treatment Effects & Transition to Survivorship for AYA Patients
|
Apr 18, 2018 |
EHR Chemotherapy Error: Breast Cancer
|
Apr 11, 2018 |
Continuity of Care for AYAs
|
Apr 04, 2018 |
Self-Evaluation: Clinical Trials Informed Consent Process
|
Mar 28, 2018 |
Self-Evaluation: Clinical Trials
|
Mar 14, 2018 |
Self-Evaluation: NSCLC
|
Feb 14, 2018 |
Self-Evaluation: Breast Cancer
|
Feb 07, 2018 |
Self-Evaluation: Metastatic Breast Cancer
|
Dec 13, 2017 |
ASCO Guidelines: Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer Update
|
Dec 06, 2017 |
Recently Approved Drugs: Nivolumab for Metastatic Colorectal Cancer
|
Nov 22, 2017 |
Self-Assessment: Metastatic Prostate Cancer
|
Nov 15, 2017 |
Recently Approved Drugs: Pembrolizumab for cHL
|
Nov 11, 2017 |
ASCO Guidelines: Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer
|
Nov 08, 2017 |
ASCO Guidelines: Management of Small Renal Masses
|
Oct 11, 2017 |
ASCO Guidelines: Potentially Curable Pancreatic Cancer
|
Aug 09, 2017 |
ASCO Guidelines: Secondary Prevention of Cervical Cancer
|
Jul 19, 2017 |
ASCO Guidelines: Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers
|
Jun 28, 2017 |
ASCO Guidelines: Pancreatic Cancer
|
May 31, 2017 |
ASCO Guidelines: Palliative Care
|
May 10, 2017 |
ASCO Guidelines: Pancreatic Cancer
|
Apr 19, 2017 |
ASCO University Weekly Podcast Series
|
Apr 19, 2017 |